PapiVax Biotech, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia (NCT07454915) | PapiVax Biotech, Inc. | 2026-04-01 |
| Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL (NCT03911076) | PapiVax Biotech, Inc. | 2019-05-22 |
Track PapiVax Biotech, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.